Invention Grant
- Patent Title: P-38 inhibitors
- Patent Title (中): P-38抑制剂
-
Application No.: US10860768Application Date: 2004-06-02
-
Publication No.: US07652044B2Publication Date: 2010-01-26
- Inventor: Qing Dong , Fabrice Pierre , Jianqiang Wang
- Applicant: Qing Dong , Fabrice Pierre , Jianqiang Wang
- Applicant Address: CH Basel
- Assignee: Novartis A.G.
- Current Assignee: Novartis A.G.
- Current Assignee Address: CH Basel
- Agent Sophie Binet Cross
- Main IPC: A61K31/421
- IPC: A61K31/421 ; A61K31/426
Abstract:
Provided are 5-membered heterocycle-based p38 kinase, including p38α and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.
Public/Granted literature
- US20040254236A1 P-38 inhibitors Public/Granted day:2004-12-16
Information query
IPC分类:
